Greenfern Industries (NZSE:GFI) ROE % : -78.96% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Greenfern Industries ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Greenfern Industries's annualized net income for the quarter that ended in Sep. 2024 was NZ$-1.31 Mil. Greenfern Industries's average Total Stockholders Equity over the quarter that ended in Sep. 2024 was NZ$1.66 Mil. Therefore, Greenfern Industries's annualized ROE % for the quarter that ended in Sep. 2024 was -78.96%.

The historical rank and industry rank for Greenfern Industries's ROE % or its related term are showing as below:

NZSE:GFI' s ROE % Range Over the Past 10 Years
Min: -82.06 Med: -56.97 Max: -56.47
Current: -82.06

During the past 3 years, Greenfern Industries's highest ROE % was -56.47%. The lowest was -82.06%. And the median was -56.97%.

NZSE:GFI's ROE % is ranked worse than
91.76% of 959 companies
in the Drug Manufacturers industry
Industry Median: 4.82 vs NZSE:GFI: -82.06

Greenfern Industries ROE % Historical Data

The historical data trend for Greenfern Industries's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenfern Industries ROE % Chart

Greenfern Industries Annual Data

Trend

Mar22

Mar23

Mar24

ROE %

-56.47

-56.97

-60.56

Greenfern Industries Semi-Annual Data
	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
ROE %	Get a 7-Day Free Trial			-52.86	-79.29	-39.85	-85.41	-78.96

Competitive Comparison of Greenfern Industries's ROE %

For the Drug Manufacturers - Specialty & Generic subindustry, Greenfern Industries's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Greenfern Industries's ROE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greenfern Industries's ROE % distribution charts can be found below:

* The bar in red indicates where Greenfern Industries's ROE % falls into.

Greenfern Industries ROE % Calculation

Greenfern Industries's annualized ROE % for the fiscal year that ended in Mar. 2024 is calculated as

ROE %	=	Net Income (A: Mar. 2024 )	/	( (Total Stockholders Equity (A: Mar. 2023 )	+	Total Stockholders Equity (A: Mar. 2024 ))	/ count )
	=	-1.573	/	( (3.264	+	1.931)	/ 2 )
	=	-1.573	/	2.5975
	=	-60.56 %

Greenfern Industries's annualized ROE % for the quarter that ended in Sep. 2024 is calculated as

ROE %	=	Net Income (Q: Sep. 2024 )	/	( (Total Stockholders Equity (Q: Mar. 2024 )	+	Total Stockholders Equity (Q: Sep. 2024 ))	/ count )
	=	-1.308	/	( (1.931	+	1.382)	/ 2 )
	=	-1.308	/	1.6565
	=	-78.96 %

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Sep. 2024) net income data. ROE % is displayed in the 30-year financial page.

Greenfern Industries (NZSE:GFI) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

	ROE %		(Q: Sep. 2024 )
=	Net Income	/	Total Stockholders Equity
=	-1.308	/	1.6565
=	(Net Income / Revenue )	*	(Revenue / Total Assets)	*	(Total Assets / Total Stockholders Equity)
=	(-1.308 / 0.488)	*	(0.488 / 2.9675)	*	(2.9675 / 1.6565)
=	Net Margin %	*	Asset Turnover	*	Equity Multiplier
=	-268.03 %	*	0.1644	*	1.7914
=	ROA %	*	Equity Multiplier
=	-44.06 %	*	1.7914
=	-78.96 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

	ROE %		(Q: Sep. 2024 )
=	Net Income	/	Total Stockholders Equity
=	-1.308	/	1.6565
=	(Net Income / Pre-Tax Income)	*	(Pre-Tax Income / Operating Income)	*	(Operating Income / Revenue)	*	(Revenue / Total Assets)	*	(Total Assets / Total Stockholders Equity)
=	(-1.308 / -1.308)	*	(-1.308 / -1.152)	*	(-1.152 / 0.488)	*	(0.488 / 2.9675)	*	(2.9675 / 1.6565)
=	Tax Burden	*	Interest Burden	*	Operating Margin %	*	Asset Turnover	*	Equity Multiplier
=	1	*	1.1354	*	-236.07 %	*	0.1644	*	1.7914
=	-78.96 %

Note: The net income data used here is two times the semi-annual (Sep. 2024) net income data. The Revenue data used here is two times the semi-annual (Sep. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
^* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.

Greenfern Industries ROE % Related Terms

Thank you for viewing the detailed overview of Greenfern Industries's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Greenfern Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greenfern Industries Ltd (NZSE:GFI) » Definitions » ROE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Albert Street, Level 8, Auckland, NTL, NZL, 1040

Website

https://www.gfi.nz

Greenfern Industries Ltd is committed to the environmentally friendly production of medicinal cannabis and hemp-based products. It operates in two segments, Cannabis and therapeutics products the operations of this segment reflect the activities of manufacture and distribution of cannabis products, Electricity generation this segment includes the generation and distribution of electricity. The hemp seed and its by-products are used for a range of different products from a high protein ingredient in a plant-based meat substitute, a hemp-based skincare range, and hemp-based beverages amongst other things.